Colorado MEDtech, Inc. VP Interviewed Regarding Medical Device Connectivity At MDM East 2001.

Business Editors & Health/Medical Writers

BOULDER, Colo.--(BW HealthWire)--June 19, 2001

Colorado MEDtech, Inc. (Nasdaq:CMED) announced today that Bill Wood, Sr. Vice President, Product Development and Technology, was interviewed during the Medical Design & Manufacturing (MD&M) East 2001 conference and exposition in New York City. The Company's exhibit, titled "Exploring the Future of Medical Device Connectivity," introduced Colorado MEDtech's design and development capabilities regarding wireless technologies and medical device connectivity applications.

Mr. Wood's interview discusses the capabilities demonstrated and their benefits to both medical device manufacturers and health care providers. To listen to the interview, go to Colorado MEDtech's website at www.cmed.com and select "MDM East 2001 webcast interview with Bill Wood -- Thursday, June 7th."

Colorado MEDtech displayed its Link IT(TM) technology that connects existing medical instrumentation to the Internet and Hospital Information Systems. The exhibit also featured a communications technology platform for both monitoring and controlling multiple devices, including vital signs monitors, IV pumps, other diagnostic and therapeutic devices using wireless networking (IEEE 802.11) and web-based technologies.

Colorado MEDtech, Inc. is a leading full-service OneSource OutSource(TM) provider of advanced medical technology outsourcing services, including device and disposables development, software, medical device connectivity, manufacturing, critical system components for medical imaging, and ultrasound accessories.

Canon Communications, LLC organized the MDM East 2001 conference and exposition; InterCast Communications Group, Inc. conducted the interviews.

Forward-Looking Statements 

The statements in this news release and the interview regarding the future technology of medical devices, trends in medical device connectivity, and the types of technology that the Company will use or develop in the future or display at future trade shows, are forward-looking statements that represent management's beliefs and assumptions based on currently available information. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it cannot assure that these expectations will prove to be correct. Such statements involve risks and uncertainties including, but not limited to, the risk that unanticipated engineering difficulties may hamper development of certain technologies referred to in the interview, the risk that technology trends in the industry do not embrace device connectivity as quickly as the Company anticipates, the risk that certain types of wireless connectivity technology may be incompatible or unsuitable for anticipated needs, the risk that the Company may not develop a mobile user interface as quickly as anticipated or containing features similar to that discussed in the interview, the risk that a downturn in general economic conditions or customer budgets may adversely affect research and development and capital expenditure budgets of potential customers upon which the Company is dependent, the risks associated with regulation by the Federal Food and Drug Administration including compliance with the Quality System Regulation, and other factors as are more fully described in the Company's documents that are filed from time to time with the Securities and Exchange Commission. Should one or more of these risks materialize (or the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those forecasted or expected. The Company disclaims any intention or obligation to update publicly or revise any forward-looking statements whether as a result of new information, future events or otherwise.